Stem cell factor receptor/c-Kit: from basic science to clinical implications.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Physiological Reviews

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/physrev.00046.2011PMID 23073628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice

  2011cited by this paper
• C-KIT Signaling Depends on Microphthalmia-Associated Transcription Factor for Effects on Cell Proliferation

  2011cited by this paper
• Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.

  2011cited by this paper
• Kinase suppressor of Ras (KSR1) modulates multiple kit-ligand-dependent mast cell functions.

  2011cited by this paper
• MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia.

  2011cited by this paper
• Core-binding factor acute myeloid leukemia.

  2011cited by this paper
• KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.

  2011cited by this paper
• c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice.

  2011cited by this paper
• Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.

  2011cited by this paper
• Mutation D816V Alters the Internal Structure and Dynamics of c-KIT Receptor Cytoplasmic Region: Implications for Dimerization and Activation Mechanisms

  2011cited by this paper
• Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.

  2010cited by this paper
• Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors.

  2010cited by this paper
• Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives

  2010cited by this paper
• Targeting Protein Kinases for Cancer Therapy

  2010cited by this paper
• Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.

  2010cited by this paper
• Structural Basis for c-KIT Inhibition by the Suppressor of Cytokine Signaling 6 (SOCS6) Ubiquitin Ligase*

  2010cited by this paper
• Signaling of c‐kit in dendritic cells influences adaptive immunity

  2010cited by this paper
• The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells.

  2010cited by this paper
• Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance.

  2010cited by this paper
• Genome‐wide analysis of POU3F2/BRN2 promoter occupancy in human melanoma cells reveals Kitl as a novel regulated target gene

  2010cited by this paper
• Strong oligomerization behavior of PDGFbeta receptor transmembrane domain and its regulation by the juxtamembrane regions.

  2010cited by this paper
• Expression of a truncated form of KIT tyrosine kinase in human spermatozoa correlates with sperm DNA integrity.

  2010cited by this paper
• Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.

  2009cited by this paper
• Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells

  2009cited by this paper
• Surface Binding Inhibitors of the SCF–KIT Protein–Protein Interaction

  2009cited by this paper
• MicroRNA-dependent regulation of cKit in cutaneous melanoma.

  2009cited by this paper
• A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis.

  2009cited by this paper
• mTOR signaling at a glance

  2009cited by this paper
• Regulation and function of NF-kappaB transcription factors in the immune system.

  2009cited by this paper
• Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells.

  2009cited by this paper
• Stem cell factor induces ERM proteins phosphorylation through PI3K activation to mediate melanocyte proliferation and migration

  2009cited by this paper
• Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics

  2009cited by this paper
• The Role of MITF Phosphorylation Sites During Coat Color and Eye Development in Mice Analyzed by Bacterial Artificial Chromosome Transgene Rescue

  2009cited by this paper
• E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.

  2009cited by this paper
• The Aberrant Localization of Oncogenic Kit Tyrosine Kinase Receptor Mutants Is Reversed on Specific Inhibitory Treatment

  2009cited by this paper
• Protein scaffolds in MAP kinase signalling.

  2009cited by this paper
• The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit.

  2009cited by this paper
• The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction*

  2009cited by this paper
• Mast cells and mastocytosis.

  2008cited by this paper
• Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib

  2008cited by this paper
• Gab2 Is Involved in Differential Phosphoinositide 3-Kinase Signaling by Two Splice Forms of c-Kit*

  2008cited by this paper
• Activation and Function of the mTORC1 Pathway in Mast Cells1

  2008cited by this paper
• Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: Report of 220 tumors and review of literature

  2008cited by this paper
• Phosphatidylinositol 3-Kinase-dependent Membrane Recruitment of Rac-1 and p47phox Is Critical for α-Platelet-derived Growth Factor Receptor-induced Production of Reactive Oxygen Species*

  2008cited by this paper
• c-kit Is Required for Cardiomyocyte Terminal Differentiation

  2008cited by this paper
• KIT associated intracellular tyrosines play an essential role in EpoR co-signaling.

  2008cited by this paper
• Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells.

  2008cited by this paper
• Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma

  2008cited by this paper
• Phylogeny of Tec family kinases identification of a premetazoan origin of Btk, Bmx, Itk, Tec, Txk, and the Btk regulator SH3BP5.

  2008cited by this paper
• Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.

  2008cited by this paper
• Protein-tyrosine Phosphatase α Regulates Stem Cell Factor-dependent c-Kit Activation and Migration of Mast Cells*

  2008cited by this paper
• Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK

  2008cited by this paper
• Stem cell factor induces HIF-1alpha at normoxia in hematopoietic cells.

  2008cited by this paper
• KIT Mutations Induce Intracellular Retention and Activation of an Immature Form of the KIT Protein in Gastrointestinal Stromal Tumors

  2008cited by this paper
• Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF).

  2008cited by this paper
• Requirement for p85alpha regulatory subunit of class IA PI3K in myeloproliferative disease driven by an activation loop mutant of KIT.

  2008cited by this paper
• Activation of c‐kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury

  2008cited by this paper
• Chrysin inhibited stem cell factor (SCF)/c-Kit complex-induced cell proliferation in human myeloid leukemia cells.

  2007cited by this paper
• Haematopoietic progenitor cells utilise conventional PKC to suppress PKB/Akt activity in response to c‐Kit stimulation

  2007cited by this paper
• Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.

  2007cited by this paper
• C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium.

  2007cited by this paper
• Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.

  2007cited by this paper
• Stem Cell Factor Attenuates Vascular Smooth Muscle Apoptosis and Increases Intimal Hyperplasia After Vascular Injury

  2007cited by this paper
• Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder

  2007cited by this paper
• Molecular detection of GNNK− and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia

  2007cited by this paper
• Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): what have we learned so far?

  2007cited by this paper
• PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.

  2007cited by this paper
• Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.

  2007cited by this paper
• Direct interaction between Kit and the interleukin-7 receptor.

  2007cited by this paper
• The tyrosine kinase FES is an essential effector of KITD816V proliferation signal.

  2007cited by this paper
• L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition

  2007cited by this paper
• Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells

  2006cited by this paper
• Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.

  2006cited by this paper
• KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group.

  2006cited by this paper
• Neoplasia Driven by Mutant c-KIT Is Mediated by Intracellular, Not Plasma Membrane, Receptor Signaling

  2006cited by this paper
• Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism

  2006cited by this paper
• Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.

  2006cited by this paper
• Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.

  2006cited by this paper
• Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma

  2006cited by this paper
• Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression.

  2006cited by this paper
• Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

  2006cited by this paper
• The Scaffolding Adapter Gab2, via Shp-2, Regulates Kit-evoked Mast Cell Proliferation by Activating the Rac/JNK Pathway*

  2006cited by this paper
• Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.

  2006cited by this paper
• The E3 ubiquitin ligase HOIL‐1 induces the polyubiquitination and degradation of SOCS6 associated proteins

  2006cited by this paper
• Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl).

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Treatment of cockroach allergen asthma model with imatinib attenuates airway responses.

  2005cited by this paper
• Acquired Resistance to Imatinib in Gastrointestinal Stromal Tumor Occurs Through Secondary Gene Mutation

  2005cited by this paper
• UVB irradiation increases the release of SCF from human epidermal cells.

  2005cited by this paper
• The systemic mastocytosis-specific activating cKit mutation D816V can be inhibited by the tyrosine kinase inhibitor AMN107

  2005cited by this paper
• Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFκB

  2005cited by this paper
• Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells.

  2005cited by this paper
• Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit

  2005cited by this paper
• Testicular germ-cell tumours in a broader perspective

  2005cited by this paper
• MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation.

  2005cited by this paper
• Genomewide linkage analysis identifies novel genetic Loci for lung function in mice.

  2005cited by this paper
• PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

  2005cited by this paper
• Compartmentalization of growth factor receptor signalling.

  2005cited by this paper
• Increased P85α Is a Potent Negative Regulator of Skeletal Muscle Insulin Signaling and Induces in Vivo Insulin Resistance Associated with Growth Hormone Excess*

  2005cited by this paper
• Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

  2005cited by this paper

• Comparative transcriptomic analysis across ovarian developmental stages in Sepiella japonica provides novel insights into its molecular regulatory mechanisms.

  2026cites this paper
• KIT Mutant/Core binding factor-negative acute myeloid leukemia might be a complex subgroup with dismal prognosis: a single-center retrospective analysis

  2026cites this paper
• Overcoming therapeutic challenges in acute myeloid leukemia: active targeting strategies by nano-drug delivery systems.

  2026cites this paper
• KIT supports small intestinal tuft cell hyperplasia.

  2026cites this paper
• Differential Responsiveness of Human Skin Mast Cells to SCF and IL-33: Reduced Reactivity to SCF but Not to IL-33 in the Post-Mitotic Phase

  2026cites this paper
• Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure.

  2026cites this paper
• Case Report: A rare case of synchronous ovarian mixed germ cell tumor and mast cell leukemia in a pediatric patient

  2026cites this paper
• Zhi Chuan Ling oral liquid alleviates Th2-type asthma via IL-4-JAK1-STAT6 and KIT signaling pathways.

  2026cites this paper
• Primordial germ cell-like cells residing in the pituitary may serve as the origin of intracranial germ cell tumors

  2026cites this paper
• EGFR/KIT-linked proliferative bias in normal breast lobules from matched non-Hispanic Black and White women is rapidly reversible by RTK inhibition.

  2026cites this paper
• Superior response and survival of intensive chemotherapy over venetoclax plus azacitidine in newly diagnosed KIT-mutated acute myeloid leukemia

  2026cites this paper
• Activin A secretion by muscle-repairing macrophages induces heterotopic ossification in mice.

  2026cites this paper
• Golgi Retention and Oncogenic Signaling of KIT Tyrosine Kinase in Gastrointestinal Stromal Tumor.

  2026cites this paper
• Environnement et domiciliation des cellules souches hématopoïétiques au cours du développement et chez l’adulte

  2025cites this paper
• Diagnostic and Prognostic Value of sCD117 in Severe Aplastic Anemia: A Cross-sectional Study

  2025cites this paper
• c‐Kit‐Mediated PI3K/AKT and Wnt/β‐Catenin Signaling Drives Resistance to 5α‐Reductase Inhibitors in Benign Prostatic Hyperplasia

  2025cites this paper
• Bispecific Aptamer-Drug Conjugates Selectively Eliminate Malignant Hematologic Cells for Treating Acute Myeloid Leukemia.

  2025cites this paper
• Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX‐622

  2025cites this paper
• Acute myeloid leukemia with t(8;21) translocation: Molecular pathogenesis, potential therapeutics and future directions.

  2025cites this paper
• Tyrosine kinase inhibitors affect sweet taste and dysregulate fate selection of specific taste bud cell subtypes via KIT inhibition

  2025cites this paper
• Kit-mediated autophagy suppression driven by a viral oncoprotein emerges as a crucial survival mechanism in Merkel cell carcinoma

  2025cites this paper
• Convergent Skeletal Muscle Cytokine Responses to TFEB Overexpression and Voluntary Wheel Running Reflect Sex-Based Variability in Exercise Adaptations

  2025cites this paper
• Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications

  2025cites this paper
• Synthesis and biological evaluation of oleanolic acid derivatives as potential c-kit inhibitors

  2025cites this paper
• Increased risk of skin cancer in mastocytosis: A large-scale retrospective cohort study of over 20,000 patients.

  2025cites this paper
• The potential role of SCF combined with DPCs in facial nerve repair

  2025cites this paper
• Pulmonary fibroblast-derived stem cell factor promotes neutrophilic asthma by augmenting IL-17A production from ILC3s

  2025cites this paper
• The Problem of Molecular Target Choice for CAR-T Cells in Acute Myeloid Leukemia Therapy

  2025cites this paper
• A Multidimensional Investigation from Electronic Properties to Biological Activity of 2-[(4-Hydroxyphenyl)iminomethyl]thiophene by DFT, HOMO-LUMO, MEP, NLO, NBO, Mulliken, Hirshfeld and Molecular Docking Analyses

  2025cites this paper
• Tuft cells restrain intestinal type 2 immunity through the transcription factor Spi-B.

  2025cites this paper
• Genome-Wide Association Study of Body Size Traits in Luning Chickens Using Whole-Genome Sequencing

  2025cites this paper
• Heterozygous deletion of exon 17 of the Kit gene impairs mouse spermatogenesis by attenuating MAPK-ERK signaling

  2025cites this paper
• Bifidobacterium animalis subsp. lactis TG11 ameliorates loperamide-induced constipation in mice by modulating gut microbiota

  2025cites this paper
• Rotenone Induces Parkinsonism with Constipation Symptoms in Mice by Disrupting the Gut Microecosystem, Inhibiting the PI3K-AKT Signaling Pathway and Gastrointestinal Motility

  2025cites this paper
• Golgi retention of KIT in gastrointestinal stromal tumour cells is phospholipase D activity-dependent

  2025cites this paper
• Herbal medicine for melanin regulation: biological synthesis, effective formulas/compounds, and biopharmaceutical methods

  2025cites this paper
• Systematic identification of Oct4 transcriptional targets in embryonic stem cells using the auxin-inducible degron system and nascent RNA sequencing

  2025cites this paper
• Effects of Bifidobacterium lactis BLa80 on fecal and mucosal flora and stem cell factor/c-kit signaling pathway in simulated microgravity rats

  2025cites this paper
• IL-7 secreted by keratinocytes induces melanogenesis via c-kit/MAPK signaling pathway in Melan-a melanocytes

  2025cites this paper
• The Prospective Use of Avapritinib in Relapsed/Refractory (R/R) RUNX1-RUNX1T1-Positive AML Patients With KIT Mutation.

  2025cites this paper
• Association between ultra-processed food consumption and inflammation: insights from the STANISLAS cohort

  2025cites this paper
• Metrnl/C‐KIT Axis Attenuates Early Brain Injury Following Subarachnoid Hemorrhage by Inhibiting Neuronal Ferroptosis

  2025cites this paper
• c-Kit signaling confers damage-resistance to sweet taste cells upon nerve injury

  2025cites this paper
• Modular Layer-by-Layer Nanoparticle Platform for Hematopoietic Progenitor and Stem Cell Targeting.

  2025cites this paper
• Targeting KIT With Antibody-Drug Conjugates in Chromophobe Renal Cell Carcinoma.

  2025cites this paper
• Spirodiclofen inhibited melanin synthesis in zebrafish embryos.

  2025cites this paper
• A comprehensive study of c-Kit–expressing amacrine cells in the mammalian retina

  2025cites this paper
• cKit Ligand (Stem Cell Factor)-Induced Immune Response via an Alternative Receptor in Human Cells

  2025cites this paper
• Distinct requirements for PI3K isoforms p110α and p110δ for PIP3 synthesis in mouse oocytes and early embryos.

  2025cites this paper
• SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation

  2025cites this paper
• Chromophobe Renal Cell Carcinoma: Emerging Vulnerabilities as a Promise for a New Therapeutic Landscape.

  2025cites this paper
• Emerging Role of Lenvatinib in Treating Platinum-Refractory Head and Neck Cancer in Resource-Limited Settings

  2025cites this paper
• DETECTION OF JAK2 V617F MUTATION IN A PATIENT WITH C-KIT POSITIVE GASTROINTESTINAL STROMAL TUMOR: CASE REPORT

  2025cites this paper
• Secondary Mutational and Cytogenetic Alterations in Core Binding Factor - Acute Myeloid Leukemia (CBF-AML): A Systematic Review and Meta-Analysis.

  2025cites this paper
• Implementation of a fully biodegradable and biomimetic epicardial patch providing synergic physico-chemical, mechanical and electrical cues for myocardial infarction therapy.

  2025cites this paper
• Enhanced Antitumor Efficacy and Reduced Myelosuppression by a Supramolecular Complex Composed of Azocalix[4]arene and Sunitinib.

  2025cites this paper
• Organoid-driven nanomedicine platform development.

  2025cites this paper
• A Canine c-kit Novel Mutation Isolated from a Gastrointestinal Stromal Tumor (GIST) Retains the Ability to Form Dimers but Lacks Autophosphorylation

  2025cites this paper
• Exploring potential causal effects of circulating inflammatory proteins on hematologic malignancies and identifying cross-cancer drug targets: a Mendelian randomization study

  2025cites this paper
• Advancing edge-based clustering and graph embedding for biological network analysis: a case study in RASopathies

  2025cites this paper
• Convergent skeletal muscle cytokine responses to TFEB overexpression and voluntary wheel running reflect sex‐based variability to exercise adaptations in mice

  2025cites this paper
• Germ cell immunoprofile and KIT exon 17 mutation guide rectification of seminoma misclassified as epithelioid gastrointestinal stromal tumor: A case report

  2025cites this paper
• Serum Olink Targeted Proteomics Identifies IL-17A as a Prospective Inflammatory Marker for the Prediction and Diagnosis of Kawasaki Disease

  2025cites this paper
• Loss of peroxisome function promotes oxidative stress induced hematopoiesis.

  2025cites this paper
• Anti-KIT antibody, briquilimab, induces mast cell apoptosis and depletion in non-human primates.

  2025cites this paper
• Well-differentiated systemic mastocytosis: genetics, mast cell immunophenotypes, and KIT autophosphorylation.

  2025cites this paper
• Impact of Molecular Evaluations in the Biology, Diagnosis and Prognostication of Patients with Mastocytosis.

  2025cites this paper
• Genetically predicted associations between circulating cytokines and autoimmune diseases: a bidirectional two-sample Mendelian randomization

  2024cites this paper
• Interventional Effects of Lactobacillus plantarum Hfy04 Isolated from Naturally Fermented Yak Yogurt on Oxazolone-Induced Colitis in BALB/c Mice

  2024cites this paper
• Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies

  2024cites this paper
• Kit Ligand and Kit receptor tyrosine kinase sustain synaptic inhibition of Purkinje cells

  2024cites this paper
• Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine

  2024cites this paper
• RAF1 facilitates KIT signaling and serves as a potential treatment target for gastrointestinal stromal tumor

  2024cites this paper
• Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases

  2024cites this paper
• Improvement of functional dyspepsia with Suaeda salsa (L.) Pall via regulating brain-gut peptide and gut microbiota structure

  2024cites this paper
• Pre‐diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population‐based cohort studies from the United States and the United Kingdom

  2024cites this paper
• Condensate-Promoting ENL Mutation Drives Tumorigenesis In Vivo Through Dynamic Regulation of Histone Modifications and Gene Expression

  2024cites this paper
• Endothelial progenitor cells control remodeling of uterine spiral arteries for the establishment of utero-placental circulation.

  2024cites this paper
• Targeting PRL phosphatases in hematological malignancies

  2024cites this paper
• A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation

  2024cites this paper
• PGR-KITLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells.

  2024cites this paper
• Efficient generation of cloned cats with altered coat colour by editing of the KIT gene.

  2024cites this paper
• New clinical trial design in precision medicine: discovery, development and direction

  2024cites this paper
• Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients

  2024cites this paper
• KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST

  2024cites this paper
• Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling

  2024cites this paper
• Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T

  2024cites this paper
• Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors

  2024influential citation
• Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment

  2024cites this paper
• Transmembrane stem factor nanodiscs enhanced revascularization in a hind limb ischemia model in diabetic, hyperlipidemic rabbits

  2024cites this paper
• PI3K/HSCB axis facilitates FOG1 nuclear translocation to promote erythropoiesis and megakaryopoiesis

  2024cites this paper
• Inhibition of CSF1R and KIT with pexidartinib reduces inflammatory signaling and cell viability in endometriosis.

  2024cites this paper
• Cytokines in hematopoietic cell transplantation and related cellular therapies.

  2024cites this paper
• Meckel’s Diverticulum in Adult Geese (Alopochen egyptiacus): A Comprehensive Study of Structure Using Histological, Electron Microscopy, and Immunohistochemical Methods

  2024cites this paper
• Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy

  2024cites this paper
• Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage

  2024cites this paper
• The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary Cancer

  2024cites this paper
• Sequence and structural insights of monoleucine-based sorting motifs contained within the cytoplasmic domains of basolateral proteins

  2024cites this paper
• Stem cell factor and cKIT modulate endothelial glycolysis in hypoxia.

  2024cites this paper
• Stem cell factor restrains endoplasmic reticulum stress-associated apoptosis through c-Kit receptor activation of JAK2/STAT3 axis in hippocampal neuronal cells

  2024cites this paper